AIM: To evaluate serum neopterin levels and their correlations with liver function tests and histological grade in children with hepatitis-B-related chronic liver disease. METHODS: The study population comprised 48 patients with chronic active hepatitis B, 32 patients with hepatitis-B-related active liver cirrhosis and 40 normal controls. Serum neopterin was measured using an enzyme-linked immunosorbent assay. RESULTS: The mean +/- SD serum neopterin levels were 14.2 +/- 5.6 nmol/L in patients with chronic hepatitis, 20.3 +/- 7.9 nmol/L in patients with liver cirrhosis and 5.2 +/- 1.4 nmol/L in control group. Serum neopterin levels were significantly higher in patients with chronic hepatitis (P = 0.005) and cirrhosis patients (P = 0.008), than in control subjects. Cirrhotic patients had significantly higher serum neopterin levels than patients with chronic hepatitis (P = 0.004). There was a positive correlation between serum neopterin levels and alanine aminotransferase levels in patients with chronic hepatitis (r = 0.41, P = 0.004) and cirrhotic patients (r = 0.39, P = 0.005). Positive correlations were detected between serum neopterin levels and inflammatory score in patients with chronic hepatitis (r = 0.51, P = 0.003) and cirrhotic patients (r = 0.49, P = 0.001). CONCLUSION: Our results suggest that serum neopterin levels can be considered as a marker of inflammatory activity and severity of disease in children with hepatitis-B-related chronic liver disease.
AIM: To evaluate serum neopterin levels and their correlations with liver function tests and histological grade in children with hepatitis-B-related chronic liver disease. METHODS: The study population comprised 48 patients with chronic active hepatitis B, 32 patients with hepatitis-B-related active liver cirrhosis and 40 normal controls. Serum neopterin was measured using an enzyme-linked immunosorbent assay. RESULTS: The mean +/- SD serum neopterin levels were 14.2 +/- 5.6 nmol/L in patients with chronic hepatitis, 20.3 +/- 7.9 nmol/L in patients with liver cirrhosis and 5.2 +/- 1.4 nmol/L in control group. Serum neopterin levels were significantly higher in patients with chronic hepatitis (P = 0.005) and cirrhosispatients (P = 0.008), than in control subjects. Cirrhoticpatients had significantly higher serum neopterin levels than patients with chronic hepatitis (P = 0.004). There was a positive correlation between serum neopterin levels and alanine aminotransferase levels in patients with chronic hepatitis (r = 0.41, P = 0.004) and cirrhoticpatients (r = 0.39, P = 0.005). Positive correlations were detected between serum neopterin levels and inflammatory score in patients with chronic hepatitis (r = 0.51, P = 0.003) and cirrhoticpatients (r = 0.49, P = 0.001). CONCLUSION: Our results suggest that serum neopterin levels can be considered as a marker of inflammatory activity and severity of disease in children with hepatitis-B-related chronic liver disease.
Authors: W Woloszczuk; J Troppmair; E Leiter; R Flener; M Schwarz; J Kovarik; E Pohanka; R Margreiter; C Huber Journal: Transplantation Date: 1986-06 Impact factor: 4.939
Authors: G Reibnegger; I Auhuber; D Fuchs; A Hausen; G Judmaier; C Prior; E R Werner; H Wachter Journal: Hepatology Date: 1988 Jul-Aug Impact factor: 17.425
Authors: R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman Journal: Hepatology Date: 1981 Sep-Oct Impact factor: 17.425
Authors: C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter Journal: J Exp Med Date: 1984-07-01 Impact factor: 14.307
Authors: Maria F Ibarra; Marisa Klein-Gitelman; Elaine Morgan; Maria Proytcheva; Christine Sullivan; Gabrielle Morgan; Lauren M Pachman; Maurice R G O'Gorman Journal: Clin Vaccine Immunol Date: 2011-01-26